Description

Technical Parameters

Introduction

GHRP22

musclepic 8

Products Description

Part 1: Classification System and Grading

From the perspective of raw material powder and application, high-quality GHRP-2 can be broadly classified into the following categories according to its application and quality management standards:

1. Pharmaceutical Grade (Pharmacopoeia or Clinical Grade)

Pharmaceutical grade GHRP-2 must meet the quality standards for pharmaceutical raw materials, with strict control over purity, impurity profiles, and residual solvents. It is typically used in the production of prescription drugs or formulations for clinical trials. This type of raw material must comply with GMP requirements in production, inspection, and record-keeping, and must be accompanied by complete Certificates of Account (COA), batch records, and stability data.

2. Research Grade (Reagent Grade)

Research grade powder is intended for non-clinical research applications. While it has high purity requirements, the testing items and limits may not be as comprehensive as those for pharmaceutical grade. It is suitable for pharmacodynamics, toxicology, in vitro, and animal experiments. Suppliers typically provide HPLC content analysis, MS mass spectrometry identification, etc., but its regulatory compliance and clinical safety documentation are not as comprehensive as pharmaceutical grade.

3. Industrial/Non-Clinical Low-Grade Products

These are batches intended for industrial use or with less stringent quality control. They are often used in non-critical processes or in agricultural or educational demonstrations. Purity and impurity control is relatively relaxed, making them unsuitable for human use or rigorous scientific research.

4. Counterfeit and Inferior Products

Some unregulated counterfeit or adulterated products exist on the market. These may contain degradation products, other peptides, or residual synthetic byproducts. Their appearance or test results may be similar to genuine products, but their quality is inconsistent. Identifying these products is a crucial part of quality management.

Part 2: Chemical Structure and Mechanism of Action (High-Level)

GHRP-2 is a short peptide, a synthetic peptide composed of several amino acids. Its typical sequence is usually represented as His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 (the specific sequence may have slight variations in different sources). It belongs to the ghrelin receptor (GHS-R1a) agonist family. In terms of mechanism of action, it stimulates the hypothalamus-pituitary axis by binding to receptors related to growth hormone secretion, inducing the release of growth hormone (GH) from the anterior pituitary gland. This description is at the physiological and pharmacological level and does not include details of clinical use or administration.

Part 3: Advantages and Research Value (Overview)

The advantages of high-quality GHRP-2 raw materials typically valued include:

1. Definite GH-promoting activity

GHRP-2 induces a measurable peak in growth hormone release in vivo, making it highly valuable for research in GH regulation, metabolism, and regenerative medicine.

2. Small molecular weight and high synthetic operability

As a short peptide, the synthesis and analysis of GHRP-2 are relatively mature. High-purity products can be easily obtained through established processes such as solid-phase peptide synthesis, facilitating formulation research.

3. Good chemical stability (under suitable conditions)

Under appropriate storage conditions (low temperature, protection from light, and dryness), high-quality GHRP-2 powder remains relatively stable, facilitating long-term storage and repackaging for research and experimentation.

4. Wide Range of Applications in Laboratory and Drug Development

GHRP-2 is frequently used as a tool molecule to investigate growth hormone release mechanisms, assess receptor activity, and explore metabolic syndrome or muscle/bone regeneration.

Part 4: Physicochemical Properties (Descriptive Level, Excluding Preparation Steps)

Common physical and chemical properties of high-quality GHRP-2 should include, but are not limited to:

1. Molecular Type and Size

GHRP-2 is a synthetic short peptide with a molecular weight in the sub-kilodalton range (commonly reported in the range of several hundred to one thousand Daltons). It differs from both small molecule drugs and large molecule proteins, and has specific analytical and preservation requirements.

2. Solubility and Solvent Selection (Overview)

As a peptide, GHRP-2 exhibits good solubility in polar solvents (such as sterile water for injection or buffer systems), but its solubility is affected by pH, salt concentration, solvent composition, and powder form (solventized or free amine/salt). Detailed solubility parameters fall under the scope of experimental procedures and are not discussed here.

3. Stability Characteristics

Peptides may undergo enzymatic hydrolysis, isomerization, or degradation in aqueous solutions and biological environments; dried lyophilized powders are more stable under low temperature, light-protected, and dry conditions. Prolonged exposure to high temperatures, strong acids, or strong alkalis will accelerate degradation. High-quality products should provide stability test data to support shelf-life claims.

4. Appearance and Color

High-quality GHRP-2 lyophilized or dry powder is generally a white to off-white amorphous or microcrystalline powder. The presence of obvious yellow, light brown, or spots may indicate oxidation, degradation, or the presence of visible impurities; such phenomena should be noted by the quality control department and the cause should be confirmed through analysis.

Part 5 Quality Standards and Testing Items

The testing system for high-quality GHRP-2 typically includes the following key items for production and quality control reference (this is a conceptual list and does not constitute operational guidelines):

1. Identification

The peptide sequence and structural characteristics are confirmed using methods such as mass spectrometry (MS), amino acid sequence analysis, peptide fingerprinting, or nuclear magnetic resonance (NMR).

2. Purity and Related Impurities

High-performance liquid chromatography (HPLC) or UPLC are commonly used methods for content and purity determination, detecting the purity of the main peak and the peak area ratio of related peptides and degradation products. Qualified pharmaceutical/research-grade products typically require high main peak purity (e.g., ≥95% or higher, depending on specific standards).

3. Residual Solvents and Heavy Metals

If organic solvents are used in synthesis or post-processing, residual solvents should be detected by methods such as gas chromatography (GC); heavy metal content must also be tested according to relevant regulatory limits.

4. Microbial Limits, Endotoxins, and Microbiological Indicators

Activities used in in vivo studies or formulation development require biosafety testing, such as total bacterial count, fungal count, and endotoxin testing, especially when subsequently used in injectable formulations.

5. Stability Testing

Accelerated and long-term stability data under packaging, temperature, humidity, and other conditions to support storage conditions and shelf-life claims.

Part 6 Application Areas (Scientific Research and Potential Pharmaceutical Directions)

1. Basic Research

GHRP-2 is commonly used to study the mechanisms of growth hormone secretion, ghrelin receptor biology, and the regulation of the pituitary-hypothalamic axis.

2. Animal Model Studies

In areas such as metabolism, muscle atrophy, and bone research, GHRP-2 can be used as a tool molecule to assess the effects of exogenous GH-promoting signals on model systems.

3. Early-Stage Drug Development

As a lead molecule or reference for receptor agonists, it is used to evaluate the pharmacological effects and safety signals of novel receptor antagonists/agonists.

4. Preclinical and Clinical Research (Regulated)

Under regulated clinical development frameworks, compliant pharmaceutical-grade GHRP-2 and its derivatives may be explored as potential drug candidates for the treatment of certain endocrine disorders, muscle atrophy, or metabolic abnormalities. Such research must undergo ethical review and regulatory approval.

Part 7 Safety, Toxicology, and Compliance Reminders (Important)

1. Safety Overview (High-Level)

As a bioactive peptide, GHRP-2 has physiological effects on the endocrine system; therefore, its use or experimental handling must strictly adhere to ethical and regulatory requirements. Any idea regarding human use must be approved through appropriate clinical trials and regulatory approvals. Unauthorized human use poses safety and legal risks.

2. Toxicology and Side Effects (Overview)

Physiological effects related to the target pathway and non-specific reactions may be observed in studies; responses may vary significantly among individuals and at different doses. Detailed toxicological data should be obtained from peer-reviewed literature or regulatory filings. No dosing or dosage recommendations are provided here.

3. Legal and Ethical Compliance

GHRP-2 has different legal statuses in different countries and regions; in some jurisdictions it is classified as an investigational chemical, limited to controlled research use; in others, unauthorized human use or sale may be illegal. Any organization or individual should consult local regulations and obtain the necessary permits before purchasing, possessing, or using it.

Part 8: Identifying High-Quality Raw Materials and Risk Warnings

When identifying high-quality GHRP-2 raw materials, pay attention to the following key points: complete Certificate of Account (COA) reports, third-party or independent laboratory test results, stability data, good production and inspection records (GMP), and a clear supply chain and product traceability. Also, be wary of common signs of counterfeit or downgraded products, such as discolored appearance, low HPLC peak, lack of endotoxin or microbial testing, and lack of traceability documentation.

Part 9: Storage, Packaging, and Transportation (Conceptual)

High-quality GHRP-2 powder is usually packaged as lyophilized powder and placed in a dry, light-protected container with a desiccant. To maintain stability, it is recommended to store at low temperatures and avoid repeated freeze-thaw cycles and humid environments. For substances requiring cross-border transportation or special management, relevant dangerous goods transportation and biological material transportation regulations and rules should be followed.

Part 10: Conclusion and Recommendations (For Research and Regulation)

GHRP-2, as a growth hormone-releasing peptide, has significant value in basic research and drug discovery. High-quality raw material powders should meet stringent quality standards in terms of purity, stability, identification, and microbiological safety, and be accompanied by comprehensive documentation and testing data. For research institutions and enterprises, it is recommended to adhere to the following when purchasing and using such raw materials: verify the supplier's qualifications and Certificate of Authorization (COA); require or conduct their own retesting of key quality indicators; comply with ethical and legal regulations; and include any human studies in a compliant clinical trial system. For individuals or those acquiring and using raw materials through unofficial channels, this should be strictly avoided, and compliant alternatives or professional consultation should be sought to minimize health and legal risks.